SCHEMBL7107793

SCHEMBL7107793

COc1c(-c2ccco2)ccc2[nH][c]nc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.35
TSHR P16473 1/20 0.35
DRD2 P14416 1/20 0.35
RAB9A P51151 4/20 0.35
NPC1 O15118 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.35
TP53 P04637 2/20 0.35
TUBB4A P04350 7/20 0.34
TUBB P07437 7/20 0.34
TUBA3C P0DPH7 7/20 0.34
TUBA1B P68363 7/20 0.34
TUBA4A P68366 7/20 0.34
TUBB4B P68371 7/20 0.34
TUBB3 Q13509 7/20 0.34
TUBB2A Q13885 7/20 0.34
TUBB8 Q3ZCM7 7/20 0.34
TUBA3E Q6PEY2 7/20 0.34
TUBA1A Q71U36 7/20 0.34
TUBA1C Q9BQE3 7/20 0.34
TUBB6 Q9BUF5 7/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7448035 0.78 TUBB4A (0.36) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL9110854 0.78 ALDH1A1 (0.36) MAPTTSHRRAB9ANPC1SMN1; SMN2
SCHEMBL10833235 0.72 KDM4E (0.36) MAPTTSHRSMN1; SMN2TP53MEN1
SCHEMBL7446479 0.72 MAPT (0.35) MAPTTSHRDRD2RAB9ANPC1
SCHEMBL26259813 0.72 DRD2 (0.41) MAPTTSHRDRD2RAB9ANPC1
SCHEMBL7106296 0.70 TUBB4A (0.36) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL27850505 0.69 MAPT (0.44) MAPTTSHRRAB9ANPC1SMN1; SMN2
SCHEMBL7107269 0.69 SMPD3 (0.39) MAPTTSHRRAB9ANPC1SMN1; SMN2
SCHEMBL6033035 0.66 HTR2A (0.38) MAPTTSHRMEN1KMT2ABLM
SCHEMBL557929 0.64 KEAP1 (0.44) MAPTRAB9ANPC1SMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030008901-A1 Hydroxy pipecolate hydroxamic acid derivatives MCCLURE KIM F (US) 2003-01-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030008901-A1 Hydroxy pipecolate hydroxamic acid derivatives MMP1, MMP10, MMP3 MAPT 3237/4885TSHR 4266/4885DRD2 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.